Skip to content

Human study to evaluate the efficacy and safety of Dendropanax morbiferus leaves extract on cognitive function improvement

Human study to evaluate the efficacy and safety of Dendropanax morbiferus leaves extract on cognitive function improvement

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0006329
Enrollment
85
Registered
2021-07-07
Start date
2021-07-31
Completion date
Unknown
Last updated
2023-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Participants who voluntarily signed a consent form for human application research on visit 1 (-2 weeks) are judged whether they are suitable for participation according to the cri

Sponsors

Ewha Womens University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Who agrees to participate in this study and signs a written agreement 2) Adult aged 50 to under 80 3) Who complains of subjective cognitive decline

Exclusion criteria

Exclusion criteria: 1) Who is suspected of having dementia as a result of a neuropsychological examination 2) Who is diagnosed with any axis 1 psychiatric disorders 3) Who has suicidal ideation 4) Who has resistant Hypertension, uncontrolled diabetes, malignancy, severe cerebrovascular disease, heart disease, neuropsychological disease, traumatic brain damage accompanied by loss of consciousness or convulsions, acute stroke, severe hearing and vision impairment 5) Who has taken medications and health functional foods that may affect cognitive and memory function 6) Any contraindications to MRI 7) Who is diagnosed with an intellectual disability or less than a high school graduate 8) Participants in other clinical studies 9) Pregnant women or lactating women or persons who have plans for pregnancy 10) Who has hypersensitivity to ingredients contained in the experimental and placebo foods or has experienced severe food allergy reactions 11) Who is deemed inappropriate by investigators to participate in this study

Design outcomes

Primary

MeasureTime frame
Cambridge Neuropsychological Test Automated Battery

Secondary

MeasureTime frame
Neuropsychological test and cognitive functional questionnaire;Brain imaging;Safety-related indicators (vital signs, clinical pathological testing);Safety-related indicators (abnormal reactions)

Countries

Korea, Republic of

Contacts

Public ContactEunji Ha

Ewha Womens University

eunji.i.ha@gmail.com+82-2-3277-6556

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026